Cohort AI Platform
AI-powered population health and healthcare analytics platform
Company profile
Company profile
Cohort is a company operating in the population health and healthcare analytics space. Based on their domain and category classification, the company likely provides AI-powered solutions for analyzing patient populations, identifying care gaps, and supporting value-based care initiatives. However, the specific details of their technology platform, target customers, and product offerings could not be determined from the available website content. The company appears to be positioned in the growing market of healthcare data analytics and population health management, which typically serves health systems, payers, and accountable care organizations seeking to improve patient outcomes while managing costs.
Company description Cohort official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
No customer types are currently listed.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered population health and healthcare analytics platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Radiology case reports · Dec 1, 2026
SingleCellMQC: A comprehensive quality control workflow for single-cell multi-omics.iScience · Sep 18, 2026
Differences in Hematopoietic Cell Transplantation Outcomes by HIV status, California, 1991-2016.Transplantation and cellular therapy · Sep 17, 2026
Variations of Blood Concentration Levels of Reactive Carbonyl Species Among Three Case-Control Studies of Breast and Colorectal Cancer.Cancer investigation · Sep 15, 2026
Postpartum Virologic Failure Among Women with HIV Suppressed at Delivery in Spain: Incidence, Timing, and Associated Factors.AIDS patient care and STDs · Sep 15, 2026
Ambient air pollutant mixtures in relation to sonographic endometrial receptivity parameters during the peri-implantation window: a clinic-based observational study.Environmental research · Sep 15, 2026
Clinical validation
NCT07666217 · Mentioned · ACTIVE NOT RECRUITING
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296 · Mentioned · RECRUITING
Multimodal Glucose Prediction in Type 2 DiabetesNCT07633171 · Mentioned · NOT YET RECRUITING
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabNCT05675410 · Mentioned · RECRUITING
Viscoelasticity Imaging to Assess Liver CancerNCT04409340 · Mentioned · RECRUITING
Novel Technologies for Respiratory Virus IdentificationNCT05661032 · Mentioned · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Cohort's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.